Dowling & Yahnke’s AstraZeneca AZN Stock Holding History

Dowling & Yahnke’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$486K	Hold	4,432	–	–	0.02%	280
2022 Q2	$586K	Hold	4,432	–	–	0.03%	260
2022 Q1	$588K	Hold	4,432	–	–	0.03%	261
2021 Q4	$516K	Hold	4,432	–	–	0.02%	273
2021 Q3	$532K	Buy	4,432 +186	+4%	+$21.7K	0.03%	262
2021 Q2	$509K	Buy	4,246 +13	+0.3%	+$1.43K	0.03%	259
2021 Q1	$421K	Hold	4,233	–	–	0.03%	265
2020 Q4	$423K	Buy	+4,233	New	+$448K	0.03%	254

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Dowling & Yahnke's AZN Position: Q3 2022 in Review

Dowling & Yahnke held its AstraZeneca (AZN) position steady in Q3 2022 at 4,432 shares worth $486K. The position accounts for 0.02% of the portfolio, ranked #280.

Dowling & Yahnke first reported a position in AZN in Q4 2020 and has held it in 8 quarters since. The position peaked at $588K in Q1 2022. 966 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

Dowling & Yahnke held 4,432 shares of AstraZeneca worth $486K as of Q3 2022.
Dowling & Yahnke left its AstraZeneca share count unchanged in Q3 2022.
AstraZeneca made up 0.02% of Dowling & Yahnke's portfolio in Q3 2022, its #280 holding.
Dowling & Yahnke first reported a position in AstraZeneca in Q4 2020 and has held it in 8 quarters since.
Dowling & Yahnke's AstraZeneca position peaked at $588K in Q1 2022.
966 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.